Education
About Us
Working with TipRanks
Follow Us
DRUP - ETF AI Analysis
Top Page
Graniteshares Nasdaq Select Disruptors Etf (DRUP)
Rating:74Outperform
Price Target:―
Positive Factors
Exposure to Leading Disruptive Companies
The ETF holds well-known technology and healthcare innovators like Microsoft, Alphabet, Meta, and Eli Lilly, giving investors access to companies at the forefront of major trends.
Focused Growth Sectors
A heavy tilt toward technology, healthcare, and communication services targets areas of the market that are often associated with long-term growth and innovation.
Meaningful Asset Base
The fund manages a sizable pool of assets, which can help support trading liquidity and ongoing fund operations.
Negative Factors
Recent Weak Performance
The ETF has shown negative returns over the past month, three months, and year to date, indicating recent performance has been weak.
High Concentration in a Few Sectors
Most of the portfolio is concentrated in technology and healthcare, which increases the risk if these growth-oriented sectors struggle.
Above-Average Expense Ratio
The fund’s expense ratio is relatively high for an ETF, which means more of the returns are eaten up by fees over time.
DRUP vs. SPDR S&P 500 ETF (SPY)
AUM49.65M
RegionNorth America
Expense Ratio0.60%
Beta1.26
IssuerGraniteShares
Inception DateOct 07, 2019
Dividend YieldN/A
Asset ClassEquity
Index TrackedNasdaq US Large Cap Select Disruptors Index - Benchmark TR Gross
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume2,299
30 Day Avg. Volume1,769
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
82.25Price Target Upside― Downside
Rating ConsensusStrong Buy
Number of Analyst Covering50
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
DRUP Summary
DRUP is an ETF that follows the Nasdaq US Large Cap Select Disruptors Index, focusing on big U.S. companies that are changing how industries work, especially in technology and healthcare. It holds well-known names like Microsoft and Alphabet (Google), along with other innovative firms in areas such as software, cybersecurity, and medical technology. Someone might invest in DRUP to seek long-term growth by backing companies driving future trends, while still getting diversification across several sectors. A key risk is that it is heavily tilted toward tech and other high-growth stocks, so its price can swing up and down more than the overall market.
How much will it cost me?The Graniteshares Nasdaq Select Disruptors ETF (DRUP) has an expense ratio of 0.6%, which means you’ll pay $6 per year for every $1,000 invested. This is higher than average because it’s actively managed, focusing on innovative large-cap companies rather than passively tracking a broad market index.
What would affect this ETF?The Graniteshares Nasdaq Select Disruptors ETF (DRUP) could benefit from continued innovation and growth in the technology and healthcare sectors, as these industries are heavily represented in its portfolio. However, rising interest rates or regulatory changes targeting large-cap tech companies may negatively impact the ETF's performance. Additionally, economic slowdowns in the U.S., its primary geographic focus, could pose challenges to the growth potential of its top holdings.
DRUP Top 10 Holdings
DRUP is leaning hard into U.S. tech disruptors, with names like Microsoft and Meta recently losing steam and acting as a bit of a brake on returns. Alphabet and Synopsys are among the brighter spots, with rising share prices helping to keep the fund’s tech engine humming. On the healthcare side, Eli Lilly is a steady, if not explosive, contributor, while device makers like Intuitive Surgical and Stryker are more mixed. Overall, this is a U.S.-centric bet on big, innovative tech and healthcare names, not a broadly diversified basket.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Microsoft | 9.50% | $4.78M | $3.07T | 0.52% | 79 Outperform | |
| Alphabet Class A | 8.74% | $4.40M | $3.92T | 76.64% | 85 Outperform | |
| Meta Platforms | 7.76% | $3.90M | $1.71T | -5.92% | 76 Outperform | |
| Eli Lilly & Co | 5.95% | $2.99M | $987.61B | 19.67% | 72 Outperform | |
| Palantir Technologies | 3.57% | $1.80M | $340.62B | 21.74% | 74 Outperform | |
| Salesforce | 2.75% | $1.38M | $181.81B | -40.50% | 80 Outperform | |
| Intuitive Surgical | 2.74% | $1.38M | $175.02B | -16.41% | 78 Outperform | |
| Stryker | 2.63% | $1.32M | $136.17B | -7.66% | 70 Outperform | |
| Vertex Pharmaceuticals | 2.40% | $1.21M | $119.47B | 3.90% | 78 Outperform | |
| Palo Alto Networks | 2.32% | $1.17M | $115.70B | -15.62% | 73 Outperform |
DRUP Technical Analysis
Negative
―
Price Trends
65.59
Negative
66.02
Negative
63.44
Negative
Market Momentum
-2.00
Positive
31.14
Neutral
11.12
Positive
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For DRUP, the sentiment is Negative. The current price of undefined is equal to the 20-day moving average (MA) of 62.93, equal to the 50-day MA of 65.59, and equal to the 200-day MA of 63.44, indicating a bearish trend. The MACD of -2.00 indicates Positive momentum. The RSI at 31.14 is Neutral, neither overbought nor oversold. The STOCH value of 11.12 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for DRUP.
DRUP Peer Comparison
Comparison Results
Performance Comparison
DRUP
Graniteshares Nasdaq Select Disruptors Etf
59.21
-1.49
-2.45%
ALTL
Pacer Lunt Large Cap Alternator ETF
―
―
―
UPSD
Aptus Large Cap Upside ETF
―
―
―
LVDS
JPMorgan Fundamental Data Science Large Value ETF
―
―
―
XOEX
Xtrackers S&P 100 Ex Top 20 ETF
―
―
―
ACEP
ARS Core Equity Portfolio ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents